Faulty transportation of messenger RNA is the culprit in neurodegenerative diseases

Faulty transportation of messenger RNA is the culprit in ALS
Fig.1 Ribosomal protein mRNA partially reversed impaired axonal outgrowth found in TDP-43-knockdown neurons. Decrease of TDP-43 in mouse cortical neurons impaired axonal outgrowth, which was significantly improved by overexpression of individual ribosomal protein mRNAs. Credit: National Center of Neurology and Psychiatry

As the current COVID-19 crisis has shown, the disruptions that occur when transportation cannot proceed as usual are system-wide, affecting individual lives, companies, and the global economy. Now imagine a similar problem inside your brain and spinal cord. A new study led by researchers from Osaka University and National Center of Neurology and Psychiatry reports that two common neurodegenerative diseases—ALS, also known as Lou Gehrig's disease, and frontotemporal lobar degeneration, or FTLD—result from reduced transportation of RNA by the protein TDP-43, which ultimately disrupts neuron function.

Because one of the biggest physiological changes in both ALS and FTLD is the disappearance of TDP-43 from the nucleoli of neurons, the team focused their research on finding out what TDP-43 normally does. TDP-43 is known to bind to RNA, and the team's first experiment showed that in neurons, TDP-43 attaches to RNA that codes for pieces of ribosomes, which are necessary for making proteins from RNA code.

At its core, transportation gets things where they need to be at the proper time, whether they're people, goods, or molecules. In the body, items being sent from one place to another are often a response to what's happening to you. For instance, in response to dehydration, your brain sends a hormone through your blood to the kidneys where it forces water to be reabsorbed. In cells like neurons, the situation is similar, but there are no roads or arteries. Instead, many molecules get to their destination by being carried by other molecules.

"We discovered TDP-43 in axons and that it binds to ribosomal protein messenger RNA," says first author Seiichi Nagano. "That was strong support for the idea that TDP-43 carries the RNA to the axon where it can be used to make ribosomal proteins. This would allow local synthesis of proteins at ribosomes built in axons." Indeed, further experiments confirmed that hypothesis and showed that when TDP-43 was missing, the RNA in question could not be transported to the axon.

Faulty transportation of messenger RNA is the culprit in ALS
Fig. 2 Model of ALS/FTLD pathology associated with abnormal deposition of TDP-43. Credit: National Center of Neurology and Psychiatry

But what happens if the RNA cannot be transported? The researchers examined axon growth in culture as well as in mouse embryos. They found that in both cases, axon extension and outgrowth were stunted when TDP-43 was missing. However, outgrowth could be restored by forcing the to overproduce ribosomal proteins.

"Now that we understand TDP-43's role in transporting the ribosomal protein messenger RNA, it should help us develop new strategies and new targets for ALS and FTLD treatments," says co-author of the study Hideki Mochizuki. "Our results in reversing stunted axon extension in mouse embryos is promising, but is just a first step."

The article, "TDP‐43 transports ribosomal mRNA to regulate axonal local translation in neuronal axons," was published in Acta Neuropathologica.


Explore further

A protein that pulls the brake on nerve growth

More information: Seiichi Nagano et al. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons, Acta Neuropathologica (2020). DOI: 10.1007/s00401-020-02205-y
Provided by Osaka University
Citation: Faulty transportation of messenger RNA is the culprit in neurodegenerative diseases (2020, September 23) retrieved 29 October 2020 from https://medicalxpress.com/news/2020-09-faulty-messenger-rna-culprit-neurodegenerative.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments